Trump Administration Reverses Opioid Ban Following Kratom Industry Lobbying
Audio narration · Coming soon
The Trump administration has decided to permit certain levels of a potent substance in products labeled as natural, reversing an earlier opioid ban. This policy change comes after lobbying efforts by the kratom industry and may benefit a GOP donor currently facing wrongful death lawsuits.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by nyt